Phase II trial of dornase alfa (PulmoXen) for the treatment of cystic fibrosis.

Trial Profile

Phase II trial of dornase alfa (PulmoXen) for the treatment of cystic fibrosis.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Dornase alfa (Primary)
  • Indications Cystic fibrosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top